Section Arrow
Quote
IPSC.NASDAQ
- Century Therapeutics
Quotes are at least 15-min delayed:2026/04/07 11:06 EDT
Regular Hours
Last
 2.15
-0.04 (-1.83%)
Day High 
2.21 
Prev. Close
2.19 
1-M High
3.04 
Volume 
825.61K 
Bid
2.15
Ask
2.16
Day Low
2.06 
Open
2.2 
1-M Low
1.934 
Market Cap 
191.42M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 2.16 
20-SMA 2.34 
50-SMA 2.2 
52-W High 3.04 
52-W Low 0.435 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.14/-1.56
Enterprise Value
231.66M
Balance Sheet
Book Value Per Share
0.88
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
109.16M
Operating Revenue Per Share
0.05
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
LNAILunai Bioworks Inc.0.3959+0.1139+40.39%-- 
SILOSilo Pharma0.5193+0.1635+45.95%-- 
CUECue Biopharma0.1777+0.0007+0.40%-- 
TERNTerns Pharmaceuticals52.625-0.155-0.29%-- 
QNCXQuince Therapeutics0.0981+0.0106+12.11%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.